BridgeBio have substantially advanced the course of an novel therapy for ATTR-CM, employing Attruby. Preliminary patient results suggests promising benefits for individuals affected with a severe condition. This focus highlights researchers’ focus to managing significant medical demands in a heart disease arena. Attruby: BridgeBio's Novel Approa